Qihan Biotech
Hangzhou
About Qihan Biotech
Qihan Biotech is a biomedical company based on genetic technology. Kaixin Bio ’s mission is to create a new world where patients do n’t have to wait for organ transplants. We are committed to using the world's advanced gene editing technology to produce safe and effective cells, tissues and organs that can be used for human transplantation, and to solve the serious shortage of organ transplant donors in China and the world.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Total funding: $116.3M
- Funding stage: Early Stage Venture
- Last round: Series B (Sep 2023)
- Website: qihanbio.com
- Phone: 0571-83500380
Industries & Categories
Biotechnology, Clinical Trials, Health Care, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/qihan-biotech-52127 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.